Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-22-000951
Filing Date
2022-09-08
Accepted
2022-09-08 14:54:16
Documents
4
Group Members
ALKALOIDA CHEMICAL CO ZRTDILIP S. SHANGHVISUN PHARMA HOLDINGSSUN PHARMACEUTICAL HOLDINGS USA, INC.SUN PHARMACEUTICAL INDUSTRIES, INC.TARO DEVELOPMENT CORP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 27 ss1234446_sc13da.htm SC 13D/A 208326
2 FOURTH JOINDER AGREEMENT ss1234446_ex9954.htm EX-99.54 3025
3 FIFTH JOINDER AGREEMENT ss1234446_ex9955.htm EX-99.55 3162
4 SIXTH JOINDER AGREEMENT ss1234446_ex9956.htm EX-99.56 2907
  Complete submission text file 0000947871-22-000951.txt   219340
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000906338 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-49231 | Film No.: 221233557
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093
Business Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093 01191228212128
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0001197089 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations